MYH9 and kidney disorder: Initial studies implicating MYH9 in nondiabetic nephropathy failed to identify coding variants associated with renal outcome[8, 9], and since the nearby nonsynonymous variants identified in APOL1 provided stronger statistical association[5–7], it was hypothesized that APOL1 variation represents the true attribution to renal disease risk.